The current institutional shareholding score of Esperion Therapeutics Inc is 5.00, ranking 73 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 66.50%, representing a quarter-over-quarter increase of 2.95%. The largest institutional shareholder is Chuck Royce, holding a total of 2.30M shares, representing 1.02% of shares outstanding, with 0.06% increase in holdings.